Aramark (ARMK)
(Delayed Data from NYSE)
$38.11 USD
+0.60 (1.60%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $38.10 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$38.11 USD
+0.60 (1.60%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $38.10 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Zacks News
Food Stocks' Earnings Roster for May 11: DAR, ARMK, BGS, VITL
by Zacks Equity Research
Food stocks are expected to reflect gains from strong demand stemming from higher at-home consumption trends amid the pandemic.
Analysts Estimate Aramark (ARMK) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Aramark (ARMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hershey's (HSY) Q1 Earnings Surpass Estimates, Sales Up
by Zacks Equity Research
Hershey's (HSY) first-quarter 2021 results reflect higher sales and earnings on strength across North America as well as International and Other unit. Also, management raises 2021 view.
Pilgrim's Pride (PPC) Q1 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) first-quarter 2021 results reflect higher sales and earnings on strength across Mexico, U.K. and Europe as well as the United States operations.
Mondelez (MDLZ) Q1 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Mondelez's (MDLZ) first-quarter 2021 earnings and revenues increase year over year. The top line gains on robust organic net sales growth.
Aramark (ARMK) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aramark (ARMK) delivered earnings and revenue surprises of 24.39% and -0.64%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Beat Your Portfolio Fatigue by Dumping These Toxic Stocks
by Rimmi Singhi
Stocks without sturdy fundamentals are toxic for your portfolio. Identifying such bloated stocks accurately and dumping them at the right time can protect your returns.
Earnings Preview: Aramark (ARMK) Q1 Earnings Expected to Decline
by Zacks Equity Research
Aramark (ARMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
eXp World Holdings, Aramark, ABM Industries, Aptiv and ManpowerGroup highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
eXp World Holdings, Aramark, ABM Industries, Aptiv and ManpowerGroup highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Aramark (ARMK)
by David Bartosiak
Earnings are under pressure in a post-COVID world.
Zacks.com featured highlights include: Cameco, Aramark, New Fortress Energy and Hexcel
by Zacks Equity Research
Zacks.com featured highlights include: Cameco, Aramark, New Fortress Energy and Hexcel
4 Toxic Stocks You Should Disown Right Away
by Rimmi Singhi
No matter how the broader market is performing, stocks without sturdy fundamentals are toxic for your portfolio and will erode your wealth.
Zacks.com featured highlights include: Aramark, Alteryx, Varex Imaging Corp and Cameco Corp
by Zacks Equity Research
Zacks.com featured highlights include: Aramark, Alteryx, Varex Imaging Corp and Cameco Corp
Dump These 4 Toxic Stocks Before It's Too Late
by Rimmi Singhi
Detecting toxic stocks and dumping them at the right time is crucial to safeguarding one's portfolio from big losses.
Company News for Nov 18, 2020
by Zacks Equity Research
Companies In The News Are: TSLA, AMZN, ARMK, KSS.
Aramark (ARMK) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Aramark (ARMK) delivered earnings and revenue surprises of -12.90% and 0.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Aramark (ARMK) Q4 Earnings Expected to Decline
by Zacks Equity Research
Aramark (ARMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Toxic Stocks That You Should Not be Owning
by Rimmi Singhi
Figuring out bloated toxic stocks on a consistent basis and discarding them at the right time is the key to successful investing.
Yes, You Can Time the Market. Find out How - September 25, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
New Strong Sell Stocks for September 21st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Yes, You Can Time the Market. Find out How - September 01, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Truth About Market Timing - August 12, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Aramark (ARMK) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aramark (ARMK) delivered earnings and revenue surprises of -6.15% and -6.42%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Aramark (ARMK) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Aramark (ARMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Truth About Market Timing - July 22, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?